Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Senseonics Holdings (SENS)
Senseonics Holdings (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 311,791
  • Shares Outstanding, K 528,281
  • Annual Sales, $ 16,390 K
  • Annual Income, $ 142,120 K
  • 60-Month Beta 0.89
  • Price/Sales 19.01
  • Price/Cash Flow 1.94
  • Price/Book 5.90
Trade SENS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings -0.04 on 11/09/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 96.59% ( -405.88%)
  • Historical Volatility 49.89%
  • IV Percentile 42%
  • IV Rank 9.36%
  • IV High 516.52% on 11/29/23
  • IV Low 53.25% on 09/21/23
  • Put/Call Vol Ratio 0.10
  • Today's Volume 537
  • Volume Avg (30-Day) 315
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 101,234
  • Open Int (30-Day) 100,682

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.04
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.05
  • Prior Year -0.01
  • Growth Rate Est. (year over year) -300.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4867 +31.37%
on 11/10/23
0.6498 -1.60%
on 12/01/23
+0.1494 (+30.49%)
since 11/01/23
3-Month
0.4606 +38.82%
on 10/30/23
0.6498 -1.60%
on 12/01/23
+0.0758 (+13.45%)
since 09/01/23
52-Week
0.4606 +38.82%
on 10/30/23
1.2700 -49.65%
on 02/03/23
-0.5206 (-44.88%)
since 12/01/22

Most Recent Stories

More News
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...

SENS : 0.6394 (+8.34%)
Senseonics Holdings (SENS) Reports Q1 Loss, Tops Revenue Estimates

Senseonics (SENS) delivered earnings and revenue surprises of 0% and 35.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SENS : 0.6394 (+8.34%)
NYXH : 4.94 (-4.73%)
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEM

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive...

SENS : 0.6394 (+8.34%)
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.6394 (+8.34%)
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) system portfolio and exclusive...

SENS : 0.6394 (+8.34%)
Top 3 Stocks to Sell in April With Weak Fundamentals

The biopharmaceutical industry has been grappling with various challenges, including inflation, the Fed’s hawkish stance, and new regulatory concerns. Hence, it could be wise to avoid Syndax Pharmaceuticals...

SENS : 0.6394 (+8.34%)
SIOX : 0.3875 (unch)
SNDX : 16.57 (-0.45%)
Senseonics Announces the First Pediatric Study Participant Insertions in the ENHANCE Clinical Trial

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.6394 (+8.34%)
Senseonics Announces Equity Grants To Employees Under Inducement Plan

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) system for people...

SENS : 0.6394 (+8.34%)
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.6394 (+8.34%)
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Lags Revenue Estimates

Sol-Gel Technologies Ltd. (SLGL) delivered earnings and revenue surprises of -92.31% and 94.60%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

SLGL : 1.3300 (+1.95%)
SENS : 0.6394 (+8.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 0.7239
2nd Resistance Point 0.6869
1st Resistance Point 0.6631
Last Price 0.6394
1st Support Level 0.6023
2nd Support Level 0.5653
3rd Support Level 0.5415

See More

52-Week High 1.2700
Fibonacci 61.8% 0.9608
Fibonacci 50% 0.8653
Fibonacci 38.2% 0.7698
Last Price 0.6394
52-Week Low 0.4606

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar